{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:45Z","timestamp":1786982145934,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11934-020-00980-5","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T22:02:36Z","timestamp":1590616956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Update on Implantable PTNS Devices"],"prefix":"10.1007","volume":"21","author":[{"given":"Annah","family":"Vollstedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gilleran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"issue":"5","key":"980_CR1","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.juro.2015.01.087","volume":"193","author":"EA Gormley","year":"2015","unstructured":"Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological Association, Society of Urodynamics, Female Pelvic Medicine. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment. J Urol. 2015;193(5):1572\u201380.","journal-title":"J Urol"},{"issue":"1","key":"980_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0022-5347(17)51928-X","volume":"129","author":"EJ Mcguire","year":"1983","unstructured":"Mcguire EJ, Shi-chun Z, Horwinski ER, Lytton B. Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol. 1983;129(1):78\u20139.","journal-title":"J Urol"},{"key":"980_CR3","doi-asserted-by":"crossref","unstructured":"Wolff G. F., R.M. Krlan., Posterior Tibial Nerve Stimulation, in Adult and Pediatric Neuromodulation, A.S. Gilleran J., Editor. 2018, Springer.","DOI":"10.1007\/978-3-319-73266-4_10"},{"issue":"4","key":"980_CR4","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.juro.2009.12.036","volume":"183","author":"KM Peters","year":"2010","unstructured":"Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438\u201343.","journal-title":"J Urol"},{"issue":"3","key":"980_CR5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.juro.2009.05.045","volume":"182","author":"KM Peters","year":"2009","unstructured":"Peters KM, MacDiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009;182(3):1055\u201361.","journal-title":"J Urol"},{"issue":"3","key":"980_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1464-410X.2006.06055.x","volume":"97","author":"F van der Pal","year":"2006","unstructured":"van der Pal F, van Balken M, Heesakkers JP, Debruyne FM, Bemelmans BL. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary? BJU Int. 2006;97(3):547\u201350.","journal-title":"BJU Int"},{"issue":"6","key":"980_CR7","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.juro.2012.11.175","volume":"189","author":"KM Peters","year":"2013","unstructured":"Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013;189(6):2194\u2013201.","journal-title":"J Urol"},{"issue":"12","key":"980_CR8","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1111\/codi.12428","volume":"15","author":"GP Thomas","year":"2013","unstructured":"Thomas GP, Dudding TC, Bradshaw E, Nicholls RJ, Vaizey CJ. A pilot study to compare daily with twice weekly transcutaneous posterior tibial nerve stimulation for faecal incontinence. Color Dis. 2013;15(12):1504\u20139.","journal-title":"Color Dis"},{"issue":"3","key":"980_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/nau.23401","volume":"37","author":"J Heesakkers","year":"2018","unstructured":"Heesakkers J, et al. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints. Neurourol Urodyn. 2018;37(3):1060\u20137 This publication shows 6-month data from 36 BlueWind RENOVA patients demonstrating safety of the technology as well as improvement in subjecive and objective OAB parameters.","journal-title":"Neurourol Urodyn"},{"key":"980_CR10","unstructured":"Digesu A E.S., Heesakkers J P F A, Van Kerrebroeck P, A prospective, multicenter, international clinical trial to assess the efficacy and safety of a novel wireless implantable tibial nerve stimulator for the treatment of patients with refractory overactive bladder (OAB): 3-years results, in International Continence Society. 2018 Philadelphia."},{"key":"980_CR11","unstructured":"BlueWind Medical. [Website. ] January 7th 2020 [cited 2020 January 10]; Available from:\nhttp:\/\/www.bluewindmedical.com\/products."},{"key":"980_CR12","unstructured":"BlueWind medical receives FDA approval for pivotal trial design of RENOVA iStim\u2122 implantable tibial nerve neuromodulator for overactive bladder. 2018, BlueWind Medical HERZLIYA, Israel p 2."},{"key":"980_CR13","doi-asserted-by":"crossref","unstructured":"Sirls L P.K., Retrograde percutaneous technique of lead placement for chronic tibial nerve stimulation, an office based procedure, in International Continence Society 2019. 2019: Goethenburg.This conference abstract demonstrates the safety of retrograde placement of the StimGuard device.","DOI":"10.1097\/01.JU.0000557488.82472.af"},{"key":"980_CR14","unstructured":"CAN-stim compared to SNS in treatment of urinary urgency incontinence with wireless neuromodulation technology (PROTECT). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02577302."},{"issue":"5","key":"980_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.juro.2018.10.017","volume":"201","author":"S MacDiarmid","year":"2019","unstructured":"MacDiarmid S, et al. Feasibility of a fully implanted, nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence. Journal of Urology. 2019;201(5):967\u201372 This publication shows 3 and 6-month data from 46 eCoin-implanted patients demonstrating safety of the technology as well as improvement in subjecive and objective OAB parameters.","journal-title":"Journal of Urology"},{"key":"980_CR16","unstructured":"Choi, J., AUA 2018: Safety & efficacy of the eCOIN\u2122 implantable tibial nerve stimulation device for overactive bladder syndrome, in AUA 2018 conference highlights, lower urinary tract conditions - nocturia 2018, Uro Today."},{"issue":"1","key":"980_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/ner.12381","volume":"19","author":"T Deer","year":"2016","unstructured":"Deer T, Pope J, Benyamin R, Vallejo R, Friedman A, Caraway D, et al. Prospective, multicenter, randomized, double-blinded, partial crossover study to assess the safety and efficacy of the novel neuromodulation system in the treatment of patients with chronic pain of peripheral nerve origin. Neuromodulation: Technology at the Neural Interface. 2016;19(1):91\u2013100.","journal-title":"Neuromodulation: Technology at the Neural Interface"},{"key":"980_CR18","unstructured":"Marcio Augusto Averbeck, J.M. Guzman Negron, Howard Goldman, Neuromodulation for lower urinary tract dysfunction \u2013 an ICS* update. 2018, Urology News."},{"key":"980_CR19","doi-asserted-by":"crossref","unstructured":"\u2022 Giusto L, Zahner P, Goldman H. V12\u201304\u2003Placement of an implantable tibial nerve stimulator under local anesthesia: step by step instructions. Journal of Urology. 2019;201(Supplement 4):e1205\u20135 This conference abstract demonstrates the safety of the procedure used for Bioness StimRouter implantation.","DOI":"10.1097\/01.JU.0000557490.67225.2d"},{"key":"980_CR20","unstructured":"Overactive bladder treatment using stimrouter neuromodulation system: a prospective randomized trial. Clinical Trials December [cited 2020 January 11]; Available from:\nhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT02873312?term=stimrouter."}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-020-00980-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-020-00980-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-020-00980-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T21:25:29Z","timestamp":1622150729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-020-00980-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["980"],"URL":"https:\/\/doi.org\/10.1007\/s11934-020-00980-5","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"28 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"28"}}